|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 176 out of 176 for Cxcl11

<< First    < Previous  |  Next >    Last >>
0.027s
Type Details Score
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Publication        
First Author: The Gene Ontology Consortium
Year: 2010
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs
Publication
First Author: Diez-Roux G
Year: 2011
Journal: PLoS Biol
Title: A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
Volume: 9
Issue: 1
Pages: e1000582
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2).
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication
First Author: Liu Z
Year: 2011
Journal: Clin Exp Immunol
Title: Chemokine CXCL11 links microbial stimuli to intestinal inflammation.
Volume: 164
Issue: 3
Pages: 396-406
Publication  
First Author: Callahan V
Year: 2021
Journal: Viruses
Title: The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Volume: 13
Issue: 6
Allele
Name: chemokine (C-X-C motif) ligand 11; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Allele
Name: transgene insertion HE40, GENSAT Project at Rockefeller University
Allele Type: Transgenic
Attribute String: Reporter
Allele
Name: transgene insertion KN257, GENSAT Project at Rockefeller University
Allele Type: Transgenic
Attribute String: Recombinase
Strain
Attribute String: mutant stock, transgenic
Strain
Attribute String: transgenic, mutant stock
Publication
First Author: Oh E
Year: 2018
Journal: Diabetes
Title: Syntaxin 4 Expression in Pancreatic β-Cells Promotes Islet Function and Protects Functional β-Cell Mass.
Volume: 67
Issue: 12
Pages: 2626-2639
Publication  
First Author: Li XM
Year: 2015
Journal: J Inflamm (Lond)
Title: Nur77 deficiency leads to systemic inflammation in elderly mice.
Volume: 12
Pages: 40
Publication
First Author: Zhang Y
Year: 2018
Journal: Am J Pathol
Title: Reversing CXCL10 Deficiency Ameliorates Kidney Disease in Diabetic Mice.
Volume: 188
Issue: 12
Pages: 2763-2773
Publication
First Author: Chen WY
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice.
Volume: 26
Issue: 9
Pages: 2090-5
Publication
First Author: Su SB
Year: 2007
Journal: Invest Ophthalmol Vis Sci
Title: Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency.
Volume: 48
Issue: 10
Pages: 4616-25
Publication
First Author: Hannesdóttir L
Year: 2013
Journal: Eur J Immunol
Title: Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.
Volume: 43
Issue: 10
Pages: 2718-29
Publication
First Author: Su YC
Year: 2008
Journal: J Immunol
Title: Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation.
Volume: 180
Issue: 4
Pages: 2600-7
Publication
First Author: Jin YZ
Year: 2008
Journal: Eur J Immunol
Title: Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.
Volume: 38
Issue: 7
Pages: 1988-98
Publication
First Author: Saxena A
Year: 2014
Journal: Cardiovasc Res
Title: CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans.
Volume: 103
Issue: 2
Pages: 217-27
Publication
First Author: Kanai K
Year: 2018
Journal: J Immunol
Title: Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27-Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin.
Volume: 200
Issue: 8
Pages: 2703-2713
Publication
First Author: Benson SA
Year: 2009
Journal: PLoS One
Title: TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.
Volume: 4
Issue: 7
Pages: e6329
Publication
First Author: Monnier J
Year: 2012
Journal: Eur J Cancer
Title: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
Volume: 48
Issue: 1
Pages: 138-48
Publication
First Author: Peng H
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity.
Volume: 479
Issue: 4
Pages: 649-655
Publication
First Author: Ameti R
Year: 2018
Journal: J Leukoc Biol
Title: Characterization of a chimeric chemokine as a specific ligand for ACKR3.
Volume: 104
Issue: 2
Pages: 391-400
Publication
First Author: Burke SJ
Year: 2016
Journal: Biofactors
Title: Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.
Volume: 42
Issue: 6
Pages: 703-715
Publication
First Author: Burns JM
Year: 2006
Journal: J Exp Med
Title: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
Volume: 203
Issue: 9
Pages: 2201-13
Publication
First Author: Gerrits H
Year: 2008
Journal: Genesis
Title: Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice.
Volume: 46
Issue: 5
Pages: 235-45
Publication
First Author: Naumann U
Year: 2010
Journal: PLoS One
Title: CXCR7 functions as a scavenger for CXCL12 and CXCL11.
Volume: 5
Issue: 2
Pages: e9175
Publication
First Author: Shimizu N
Year: 2000
Journal: J Virol
Title: A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses.
Volume: 74
Issue: 2
Pages: 619-26
Publication
First Author: Rajagopal S
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
Volume: 107
Issue: 2
Pages: 628-32
Publication
First Author: Hattermann K
Year: 2010
Journal: Cancer Res
Title: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Volume: 70
Issue: 8
Pages: 3299-308
Publication
First Author: Miao Z
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Volume: 104
Issue: 40
Pages: 15735-40
Publication
First Author: Zabel BA
Year: 2009
Journal: J Immunol
Title: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Volume: 183
Issue: 5
Pages: 3204-11
Protein Domain
Type: Family
Description: Just like classical chemokine receptors, atypical chemokine receptors (ACKRs) are seven-transmembrane-helix (7TM) receptors that bind chemokines []. However, they lack the canonical DRYLAIV motif necessary for GPCR coupling to G proteins and induction of classical signalling pathways. Instead, ACKRs internalise their chemokine ligands, which may subsequently affect chemokine availability. The ACKR family comprises five members: Duffy Antigen Receptor for Chemokines (DARC, ACKR1), D6 (ACKR2), CXCR7 (ACKR3), CCRL1 (ACKR4) and CCRL2 (ACKR5) [].Atypical chemokine receptor 3 (ACKR3), previously known as CXC chemokine receptor 7 (CXCR7), is regarded as a scavenger for CXCL12 and, to a lesser extent, for CXCL11 []. Unlike other CXC chemokine receptors, ACKR3 does not elicit classical chemokine receptor signalling via typical G protein-mediated pathways [], but instead induces beta-arrestin recruitment, leading to ligand internalisation and activation of MAPK signaling pathway [, ].ACKR3/CXCR7 has been identified on memory B cells and in mammals is found in bone, brain, heart and kidney [, ]. It has been shown to act as a novel coreceptor for several immunodeficiency virus strains, which infect brain-derived cells []. Studies in zebrafish have also revealed a critical role in vascular formation and angiogenesis during development []. ACKR3/CXCR7 is a functional receptor for CXCL12 in astrocytomas/glioblastomas and mediates resistance to drug-induced apoptosis []. It has been shown to promote growth of tumors formed from breast and lung cancer cells [].
Publication
First Author: Batdorf HM
Year: 2023
Journal: Am J Physiol Endocrinol Metab
Title: NOD mice have distinct metabolic and immunologic profiles when compared with genetically similar MHC-matched ICR mice.
Volume: 325
Issue: 4
Pages: E336-E345
Publication
First Author: Nibbs RJ
Year: 2013
Journal: Nat Rev Immunol
Title: Immune regulation by atypical chemokine receptors.
Volume: 13
Issue: 11
Pages: 815-29
Publication
First Author: Bachelerie F
Year: 2014
Journal: Nat Immunol
Title: New nomenclature for atypical chemokine receptors.
Volume: 15
Issue: 3
Pages: 207-8
Publication
First Author: Weng Y
Year: 1998
Journal: J Biol Chem
Title: Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.
Volume: 273
Issue: 29
Pages: 18288-91
Publication
First Author: Loetscher M
Year: 1996
Journal: J Exp Med
Title: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.
Volume: 184
Issue: 3
Pages: 963-9
Publication
First Author: García-López MA
Year: 2001
Journal: Lab Invest
Title: CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells.
Volume: 81
Issue: 3
Pages: 409-18
Publication
First Author: Booth V
Year: 2002
Journal: Biochemistry
Title: The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.
Volume: 41
Issue: 33
Pages: 10418-25
Publication
First Author: Smit MJ
Year: 2003
Journal: Blood
Title: CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase.
Volume: 102
Issue: 6
Pages: 1959-65
Publication
First Author: Hancock WW
Year: 2000
Journal: J Exp Med
Title: Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
Volume: 192
Issue: 10
Pages: 1515-20
Publication
First Author: Mach F
Year: 1999
Journal: J Clin Invest
Title: Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.
Volume: 104
Issue: 8
Pages: 1041-50
Publication
First Author: Jiang D
Year: 2004
Journal: J Clin Invest
Title: Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
Volume: 114
Issue: 2
Pages: 291-9
Publication
First Author: Frigerio S
Year: 2002
Journal: Nat Med
Title: Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.
Volume: 8
Issue: 12
Pages: 1414-20
Publication
First Author: Panzer U
Year: 2007
Journal: J Am Soc Nephrol
Title: Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice.
Volume: 18
Issue: 7
Pages: 2071-84
Publication
First Author: Qin S
Year: 1998
Journal: J Clin Invest
Title: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Volume: 101
Issue: 4
Pages: 746-54
Publication
First Author: Curbishley SM
Year: 2005
Journal: Am J Pathol
Title: CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.
Volume: 167
Issue: 3
Pages: 887-99
Publication  
First Author: Loetscher P
Year: 2000
Journal: Adv Immunol
Title: Chemokines and their receptors in lymphocyte traffic and HIV infection.
Volume: 74
Pages: 127-80
Publication
First Author: Zlotnik A
Year: 1999
Journal: Crit Rev Immunol
Title: Recent advances in chemokines and chemokine receptors.
Volume: 19
Issue: 1
Pages: 1-47
Publication
First Author: Yates CC
Year: 2007
Journal: Am J Pathol
Title: Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor.
Volume: 171
Issue: 2
Pages: 484-95
Publication
First Author: Xanthou G
Year: 2003
Journal: Eur J Immunol
Title: CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Volume: 33
Issue: 8
Pages: 2241-50
Protein Domain
Type: Family
Description: Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.This entry represents CXCR3, which is expressed in natural killer cells and activated T lymphocytes but not in resting T lymphocytes, B lymphocytes, monocytes or granulocytes [, ]. CXCR3 also appears to be constitutively expressed on endothelial cells of medium and large blood vessels []. CXCR3 is able to regulate leukocyte trafficking and binding to various chemokines inducing various cellular responses, most notably integrin activation, cytoskeletal changes and chemotactic migration [, , , ]. The main role of CXCR3 is the selective recruitment of effector T cells in both normal tissues and inflammation []and it is involved in a number of T cell-mediated inflammatory diseases, such as autoimmune diseases, delayed-type hypersensitivity responses, certain viral diseases and acute transplant rejection []. It has been implicated in atherosclerosis [], pulmonary fibrosis [], type 1 diabetes []and nephrotoxic nephritis [], and has been implicated in wound healing [].CXCR3 is the receptor for CXCL9 (Mig), CXCL10 (IP10) and CXCL11 (I-TAC), [, , , ], which are upregulated in response to interferon-gamma and are potent chemoattractants for activated T cells [, ]. All three chemokines elicit an increase in intracellular Ca2+ levels and activate phosphoinositide 3-kinase and mitogen-activated protein kinase (MAPK) []. CXCR3 is also capable of binding a number of CC chemokines with moderate affinity, including CCL11 (eotaxin), CCL13, CCL20, CCL7, CCL5 []. However, it has been reported that CCL11, despite binding with high affinity, may be neither an agonist or an antagonist of the CXCR3 receptor, but sequesters available CCL11 resulting in a lowered response at other receptors [].
Protein
Organism: Mus musculus/domesticus
Length: 362  
Fragment?: false
Publication
First Author: Murphy PM
Year: 2000
Journal: Pharmacol Rev
Title: International union of pharmacology. XXII. Nomenclature for chemokine receptors.
Volume: 52
Issue: 1
Pages: 145-76
Protein
Organism: Mus musculus/domesticus
Length: 367  
Fragment?: false
Publication
First Author: Ma Q
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
Volume: 95
Issue: 16
Pages: 9448-53
Publication
First Author: Horuk R
Year: 2001
Journal: Cytokine Growth Factor Rev
Title: Chemokine receptors.
Volume: 12
Issue: 4
Pages: 313-35
Publication
First Author: Charbonnier AS
Year: 1999
Journal: J Exp Med
Title: Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells.
Volume: 190
Issue: 12
Pages: 1755-68
Publication
First Author: Sallusto F
Year: 1998
Journal: J Exp Med
Title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.
Volume: 187
Issue: 6
Pages: 875-83
Publication
First Author: Strieter RM
Year: 1995
Journal: J Biol Chem
Title: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
Volume: 270
Issue: 45
Pages: 27348-57
Publication
First Author: Zlotnik A
Year: 2000
Journal: Immunity
Title: Chemokines: a new classification system and their role in immunity.
Volume: 12
Issue: 2
Pages: 121-7
Publication      
First Author: The Gene Expression Nervous System Atlas (GENSAT) Project, The Rockefeller University (New York, NY)
Year: 2005
Journal: Database Download
Title: MGI download of GENSAT transgene data